AN2690
Side effects
Options: Hide MedDRA Preferred Terms
| MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels |
|---|---|---|---|---|
| 1 | ||||
| Application site exfoliation | Application site exfoliation | 0.253% - 2.65% | x | |
| Ingrowing nail | Ingrowing nail | 0.253% - 2.53% | x | |
| Application site erythema | Application site erythema | 0% - 1.64% | x | |
| Application site rash | Application site rash | 0% - 1.26% | x | |
| Skin irritation | Skin irritation | x | ||
Indications
No indications were found.
Color scheme:
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |
